Ureteral Access Sheath Market Size, Share, Growth, and Industry Analysis, By Type ( Inner Diameter Fr below 10,Inner Diameter Fr 10-12,Inner Diameter Fr 13-15 ), By Application ( Clinic,Hospital ), Regional Insights and Forecast to 2035

Ureteral Access Sheath Market Overview

The global Ureteral Access Sheath Market size estimated at USD 440.51 million in 2026 and is projected to reach USD 569.75 million by 2035, growing at a CAGR of 3.74% from 2026 to 2035.

The Ureteral Access Sheath Market is characterized by increasing procedural volumes in urology, with over 2.1 million ureteroscopy procedures performed globally each year, of which 35%–45% involve ureteral access sheaths. Device adoption has risen due to improved surgical efficiency, reducing intrarenal pressure by 40%–60% during procedures. The average sheath diameter ranges from 9.5 Fr to 14 Fr, with 12 Fr accounting for nearly 38% usage. Single-use devices dominate with over 65% preference due to infection control protocols. The Ureteral Access Sheath Market Analysis highlights rising kidney stone prevalence, affecting 10%–15% of the global population, directly influencing demand.

In the United States, the Ureteral Access Sheath Market shows strong penetration, with over 1.2 million kidney stone cases treated annually, and over 500,000 ureteroscopy procedures conducted each year. Approximately 55%–60% of these procedures utilize access sheaths, driven by standardized clinical guidelines. The Ureteral Access Sheath Market Size in the U.S. is supported by hospital-based procedures accounting for 78% of usage, while outpatient clinics contribute 22%. Disposable sheath usage exceeds 70% due to strict infection prevention norms. Additionally, the prevalence of urolithiasis in the U.S. is approximately 11%, with recurrence rates reaching 50% within 5 years, supporting sustained market demand.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing urolithiasis incidence accounts for 12%–15% global prevalence, while ureteroscopy adoption exceeds 65% procedural preference, and sheath utilization improves surgical efficiency by 45%–55%, with complication reduction rates near 30%–40%, driving consistent procedural demand growth.
• Major Market Restraint: High device costs impact 35%–40% of healthcare facilities, while reusable alternatives reduce adoption by 20%–25%, and complications such as ureteral injury occur in 5%–9% of cases, limiting widespread sheath utilization across emerging markets by 15%–20%.
• Emerging Trends: Single-use sheath adoption exceeds 65%–70%, while hydrophilic coating usage improves insertion efficiency by 50%–60%, and miniaturized sheath demand grows by 30%–35%, reflecting rising preference for minimally invasive urological procedures globally by 55%–60%.
• Regional Leadership: North America leads with 40%–45% market share, followed by Europe at 25%–30%, while Asia-Pacific accounts for 20%–25%, and Middle East & Africa contributes 5%–10%, reflecting procedural volumes and healthcare infrastructure disparities.
• Competitive Landscape: Top 2 players hold approximately 35%–40% combined share, while mid-tier companies contribute 30%–35%, and emerging manufacturers account for 20%–25%, with product innovation influencing 50%–60% of competitive positioning across the Ureteral Access Sheath Market.
• Market Segmentation: Inner diameter 10–12 Fr dominates with 38%–42% share, followed by 13–15 Fr at 30%–34%, while below 10 Fr accounts for 20%–25%, and hospital applications contribute 75%–80%, compared to clinics at 20%–25%.
• Recent Development: New product launches increased by 25%–30% between 2023–2025, while hydrophilic coating enhancements improved performance by 45%–50%, and disposable device approvals rose by 35%–40%, accelerating innovation across the Ureteral Access Sheath Industry Analysis.

Latest Trends

The Ureteral Access Sheath Market Trends highlight a significant shift toward minimally invasive urological procedures, with ureteroscopy procedures increasing by 18%–22% over the last 5 years. Disposable ureteral access sheaths now account for 65%–70% of total usage, driven by infection control standards and reduced cross-contamination risks. Hydrophilic-coated sheaths have demonstrated 50% lower insertion force, improving procedural outcomes and reducing ureteral trauma rates by 25%–30%.

Technological advancements in sheath design have led to improved flexibility and kink resistance, enhancing surgical efficiency by 40%–45%. Smaller diameter sheaths (below 10 Fr) are gaining traction, especially in pediatric and complex cases, contributing to 20%–25% of total demand. Additionally, digital ureteroscopy integration has increased sheath utilization rates by 35%–40%, as better visualization requires stable access pathways.

The Ureteral Access Sheath Market Insights also indicate rising outpatient procedures, with ambulatory surgical centers performing 30%–35% of ureteroscopy procedures, boosting demand for cost-effective and disposable devices. Emerging markets are witnessing 15%–20% annual procedural growth, supported by increasing awareness and improved diagnostic rates.

Market Dynamics

The Ureteral Access Sheath Market Dynamics are shaped by increasing urological disease burden, technological advancements, and procedural efficiency improvements across more than 2.1 million ureteroscopy procedures performed annually worldwide. The Ureteral Access Sheath Market Growth is influenced by rising kidney stone prevalence of 10%–15% globally, increasing adoption of minimally invasive procedures exceeding 65%, and improved clinical outcomes with sheath usage reducing intrarenal pressure by 40%–60%. At the same time, challenges such as complication risks of 5%–9%, cost pressures affecting 35%–40% of facilities, and regulatory compliance delays of 20%–30% shape the overall Ureteral Access Sheath Market Outlook.

DRIVER

Increasing prevalence of kidney stones and rising minimally invasive procedures

The primary driver in the Ureteral Access Sheath Market is the growing incidence of urolithiasis, affecting approximately 10%–15% of the global population, with recurrence rates reaching 30%–50% within 5 years. Ureteroscopy has become the preferred treatment method, accounting for more than 65% of all kidney stone procedures, directly increasing the demand for ureteral access sheaths. The use of access sheaths improves procedural efficiency by 40%–45%, reduces operative time by 20%–30%, and lowers intrarenal pressure by 40%–60%, minimizing infection risks. Additionally, aging populations, representing 16%–18% globally, are more prone to urological conditions, further driving procedural volumes. Hospitals report that sheath usage enhances surgical outcomes in 55%–60% of cases, reinforcing its importance in modern urology practice within the Ureteral Access Sheath Market Analysis.

RESTRAINT

Risk of ureteral injury and high procedural costs

One of the key restraints in the Ureteral Access Sheath Market is the risk of complications associated with sheath insertion, including ureteral wall injury, which occurs in approximately 5%–9% of cases. These risks are higher with larger diameter sheaths, particularly those in the 13–15 Fr range, where complication rates can reach 6%–8%. Additionally, cost constraints affect adoption, with 35%–40% of healthcare facilities in developing regions preferring reusable devices over disposable sheaths. The cost of advanced hydrophilic-coated sheaths is 20%–25% higher than standard devices, limiting their use in price-sensitive markets. Furthermore, lack of skilled professionals impacts 20%–25% of procedures, as improper handling increases complication risks. Reimbursement challenges in certain regions also reduce procedural accessibility by 15%–20%, affecting overall market penetration.

OPPORTUNITY

Expansion in emerging markets and outpatient procedures

The Ureteral Access Sheath Market Opportunities are significant in emerging economies, where healthcare infrastructure investments are increasing by 10%–15% annually. Asia-Pacific and Latin America are witnessing growth in ureteroscopy procedures by 20%–25% per year, driven by improved diagnostic capabilities and rising awareness of urological disorders. Outpatient procedures now account for 30%–35% of total urology interventions, creating demand for cost-effective and disposable sheath solutions. Local manufacturing initiatives have reduced device costs by 15%–20%, making them more accessible. Additionally, partnerships between global manufacturers and regional distributors have increased market penetration by 30%–35%. Technological advancements, including miniaturized sheaths and improved coatings, are expanding application areas by 25%–30%, further enhancing growth opportunities within the Ureteral Access Sheath Market Forecast.

CHALLENGE

Regulatory barriers and product standardization issues

The Ureteral Access Sheath Market faces challenges related to stringent regulatory requirements and lack of product standardization. Compliance with medical device regulations increases product development timelines by 20%–30%, delaying market entry for new innovations. Variability in product quality across manufacturers affects approximately 15%–20% of procedures, leading to inconsistent clinical outcomes. Additionally, sterilization and disposal regulations for single-use devices increase operational costs by 10%–15%, particularly in developed regions. Supply chain disruptions impact 25%–30% of manufacturers, affecting product availability and distribution efficiency. Training gaps among healthcare professionals also persist, with 20%–25% of practitioners requiring additional training for optimal sheath usage. These challenges collectively influence the Ureteral Access Sheath Market Insights and require strategic solutions for sustained growth.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Segmentation Analysis

The Ureteral Access Sheath Market Segmentation is structured by type and application, reflecting clinical requirements and procedural complexity across 2.1 million annual ureteroscopy procedures globally. By type, Inner Diameter Fr 10–12 dominates with 38%–42% share, followed by 13–15 Fr at 30%–34%, and below 10 Fr at 20%–25%. By application, hospitals lead with 75%–80% share, while clinics account for 20%–25%, driven by infrastructure availability and case volume. The Ureteral Access Sheath Market Analysis indicates that over 65% of procedures utilize mid-range diameters, ensuring optimal balance between flexibility and instrument compatibility.

By Type

Inner Diameter Fr below 10: This segment accounts for approximately 20%–25% of the Ureteral Access Sheath Market Share, primarily used in pediatric and anatomically complex cases. These sheaths reduce ureteral trauma by 30%–35%, making them suitable for delicate procedures. However, limited compatibility with standard ureteroscopes restricts adoption to 15%–20% of total procedures. Demand for smaller diameters has increased by 18%–22%, particularly in specialized urology centers. Additionally, advancements in miniaturized devices have improved maneuverability by 25%–30%, supporting growth in this segment within the Ureteral Access Sheath Market Trends.

Inner Diameter Fr 10–12: The 10–12 Fr segment dominates the Ureteral Access Sheath Market Size with 38%–42% share, as it is used in approximately 60%–65% of ureteroscopy procedures. These sheaths provide optimal irrigation flow, improving visualization by 35%–40%, and enhance surgical efficiency by 40%–45%. Hydrophilic coatings, present in over 70% of products in this category, reduce insertion resistance by 50%–60%, minimizing complications. The segment has witnessed adoption growth of 20%–25%, driven by its compatibility with a wide range of instruments and its ability to balance safety and performance.

Inner Diameter Fr 13–15: The 13–15 Fr segment holds 30%–34% of the Ureteral Access Sheath Market Share, primarily used in complex stone removal procedures requiring higher irrigation flow rates. These sheaths improve stone fragment extraction efficiency by 30%–35% and enhance visualization during surgery by 35%–40%. However, the risk of ureteral injury is slightly higher, occurring in 6%–8% of cases, which limits usage in sensitive patient groups. Despite this, demand has grown by 15%–18%, particularly in tertiary care hospitals handling high-volume urology cases.

By Application

Clinic: Clinics represent 20%–25% of the Ureteral Access Sheath Market Size, with increasing adoption in outpatient and ambulatory settings. Procedure volumes in clinics have grown by 25%–30%, driven by shorter recovery times and cost efficiency. Approximately 30%–35% of ureteroscopy procedures are now performed in outpatient settings, boosting demand for disposable sheaths. Clinics prefer single-use devices in over 65% of cases, reducing sterilization requirements and minimizing infection risks by 20%–25%. The Ureteral Access Sheath Market Insights highlight that clinic-based procedures are expanding rapidly due to improved accessibility and patient convenience.

Hospital: Hospitals dominate the Ureteral Access Sheath Market Outlook with 75%–80% share, performing more than 70% of complex urology procedures globally. Sheath utilization rates in hospitals exceed 60%–65%, supported by advanced infrastructure and skilled professionals. High patient inflow, with over 1.5 million hospital-based ureteroscopy procedures annually, drives consistent demand. Hospitals also account for 70%–75% of purchases of advanced hydrophilic-coated sheaths, reflecting their focus on improved surgical outcomes. Additionally, integration of advanced imaging technologies has increased sheath usage by 35%–40%, strengthening the dominance of hospitals in the Ureteral Access Sheath Market Research Report.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Regional Outlook

The Ureteral Access Sheath Market Outlook demonstrates strong regional variation, with global procedure volumes exceeding 2.1 million annually and adoption rates ranging between 35%–45% across developed regions. North America leads with approximately 32%–35% market share, followed by Europe at 25%–30%, Asia-Pacific at 20%–25%, and Middle East & Africa at 5%–10%. Growth across all regions is supported by increasing kidney stone prevalence of 10%–15% globally, rising minimally invasive procedure adoption above 65%, and expanding healthcare infrastructure investments of 10%–15% annually in emerging markets.

North America

North America dominates the Ureteral Access Sheath Market with approximately 32%–35% share, driven by high urology procedure volumes and advanced healthcare infrastructure. The region performs over 600,000 ureteroscopy procedures annually, with sheath utilization rates exceeding 60%–65%. The United States contributes nearly 80%–85% of regional demand, supported by kidney stone prevalence of 10%–12% and recurrence rates reaching 50% within 5 years. Adoption of disposable sheaths exceeds 70%, reflecting strict infection control regulations and hospital protocols. Technological penetration in North America is above 65%, with hydrophilic-coated and dual-lumen sheaths improving procedural efficiency by 40%–50%. Additionally, outpatient procedures account for 30%–35% of total interventions, further increasing demand for single-use devices. High healthcare expenditure, accounting for nearly 16%–18% of GDP, supports continued adoption and innovation across the Ureteral Access Sheath Market Insights.

Europe

Europe holds 25%–30% share in the Ureteral Access Sheath Market Analysis, with over 400,000 ureteroscopy procedures performed annually across key countries. Germany, France, and the UK contribute approximately 55%–60% of regional demand, supported by well-established healthcare systems. Sheath utilization rates in Europe range between 50%–55%, with disposable device adoption reaching 60%–65% in Western Europe. Clinical guidelines promote minimally invasive procedures, increasing adoption by 20%–25% over recent years. Eastern Europe is witnessing growth of 15%–20%, driven by rising healthcare investments and improved access to advanced urology devices. Additionally, aging populations, representing 18%–20% of total demographics, contribute to higher incidence of urological disorders. Technological advancements, including improved sheath flexibility and pressure control systems, have enhanced procedural success rates by 35%–40%, strengthening Europe’s position in the Ureteral Access Sheath Market Outlook.

Asia-Pacific

Asia-Pacific accounts for 20%–25% share and represents the fastest-growing region in the Ureteral Access Sheath Market Forecast. The region performs over 500,000 ureteroscopy procedures annually, with growth rates of 20%–25% in procedural volumes. China and India collectively contribute 50%–55% of regional demand, supported by large patient populations and kidney stone prevalence of 12%–15%. Healthcare infrastructure expansion has increased hospital capacity by 15%–20%, improving access to advanced surgical devices. Local manufacturing has reduced device costs by 15%–20%, boosting adoption rates in cost-sensitive markets. Japan and South Korea contribute 15%–18% of regional share, with high adoption of advanced technologies exceeding 65%. Additionally, awareness campaigns have improved diagnostic rates by 25%–30%, further driving demand across the Ureteral Access Sheath Market Research Report.

Middle East & Africa

The Middle East & Africa region holds 5%–10% share in the Ureteral Access Sheath Market Size, with gradual growth driven by healthcare modernization. Gulf Cooperation Council (GCC) countries account for 60%–65% of regional demand, supported by healthcare investments increasing by 12%–15% annually. Ureteroscopy procedure volumes in the region exceed 120,000 annually, with sheath utilization rates between 30%–40%. Africa represents a smaller share, with adoption levels below 25%, due to limited healthcare infrastructure and affordability constraints. However, government initiatives and international collaborations have improved access to urological care by 15%–20%. Increasing awareness and diagnostic improvements have led to a 20%–25% rise in reported urolithiasis cases, supporting future demand. Technological adoption remains moderate at 35%–40%, but is expected to improve with ongoing investments and training programs across the Ureteral Access Sheath Market Opportunities.

List of Top Ureteral Access Sheath Companies

• Applied Medical
• Coloplast
• Envaste
• Boston Scientific
• Amecath
• Olympus
• Cook Medical
• BD
• Rocamed

Top Two Companies with Highest Market Share

• Boston Scientific – holds approximately 18%–22% market share, driven by extensive product portfolio and global presence in over 100 countries.
• Cook Medical – accounts for 12%–15% market share, with strong distribution networks and product adoption in 80% of major hospitals globally.

Investment Analysis and Opportunities

The Ureteral Access Sheath Market Investment Analysis highlights strong capital inflows driven by the rising burden of urological disorders, with kidney stone prevalence affecting nearly 10%–12% of the global population and contributing to over 2 million ureteroscopy procedures annually. Increasing adoption of minimally invasive surgeries, which account for over 65% of urology interventions, has encouraged both public and private investments in endourology infrastructure. Healthcare spending in emerging economies has increased by 10%–15% annually, enabling hospitals to expand advanced surgical capabilities and improve access to ureteral access sheath devices.

Private investments and venture funding in medical devices have grown by 20%–25%, with approximately 40%–45% of funding directed toward disposable and single-use technologies. Single-use ureteral access sheaths now represent 65%–70% of new procurement demand, driven by infection control protocols and regulatory requirements. Additionally, mergers and acquisitions activity has increased by 15%–20%, as major manufacturers expand urology portfolios and strengthen global distribution networks. Strategic collaborations between device manufacturers and healthcare providers have risen by 30%–35%, improving product accessibility and clinical adoption rates.

New Product Development

New product development in the Ureteral Access Sheath Market is strongly focused on enhancing procedural safety, device efficiency, and compatibility with advanced urology systems. Approximately 34% of newly developed sheaths incorporate reinforced distal tips, reducing insertion-related trauma and improving navigation through complex ureter anatomy. Hydrophilic coating innovations have reduced insertion force by nearly 28%–60%, significantly improving surgeon control and lowering complication risks.

Manufacturers are increasingly adopting thinner wall engineering, enabling internal lumen expansion by nearly 12% without increasing outer diameter, which enhances irrigation flow and instrument passage efficiency. Around 63% of newly launched products are compatible with digital ureteroscopes below 8.5 Fr, reflecting the integration of advanced imaging technologies into urology procedures. Additionally, approximately 40% of new devices include radiopaque markers, improving visualization accuracy during fluoroscopic guidance.

Five Recent Developments (2023–2025)

1. In 2023, a leading manufacturer introduced a hydrophilic-coated sheath reducing insertion force by 55%.
2. In 2024, disposable sheath production increased by 35%, addressing infection control requirements.
3. In 2023, a new kink-resistant design improved flexibility by 40%, enhancing procedural efficiency.
4. In 2025, miniaturized sheaths below 10 Fr saw 25% higher adoption in pediatric procedures.
5. In 2024, global distribution networks expanded by 30%, increasing product availability in emerging markets.

Report Coverage

The Ureteral Access Sheath Market Report provides an in-depth evaluation of industry performance across 15+ countries and analyzes data from 50+ manufacturers, covering over 85% of global product supply. The Ureteral Access Sheath Market Analysis includes detailed insights into procedural volumes, with more than 2.1 million ureteroscopy procedures conducted annually, and sheath utilization rates ranging between 35%–45%. The report scope incorporates 3 primary product types and 2 major application segments, ensuring comprehensive segmentation mapping across 100% of the market landscape.

The Ureteral Access Sheath Industry Report further includes analysis of 10+ key market players, collectively accounting for 70%–75% of total market share, along with evaluation of 25+ emerging companies contributing approximately 20%–25% share. It assesses technological advancements such as hydrophilic coatings, which improve insertion efficiency by 50%–60%, and single-use devices representing 65%–70% of product adoption. The Ureteral Access Sheath Market Research Report also examines regional distribution, highlighting North America with 40%–45% share, Europe with 25%–30%, Asia-Pacific with 20%–25%, and Middle East & Africa with 5%–10%.

Ureteral Access Sheath Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 440.51 Billion in 2026
Market Size Value By	USD 569.75 Billion by 2035
Growth Rate	CAGR of 3.74% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Inner Diameter Fr below 10 Inner Diameter Fr 10-12 Inner Diameter Fr 13-15 By Application : Clinic Hospital
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample